Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Michihiro Ogasawara, Michiaki Kageyama, Makio Kusaoi, Shin Onuma, Takayuki Kon, Fumio Sekiya, Kaoru Sugimoto, Ran Matsudaira, Masakazu Matsushita, Kurisu Tada, Kazuo Kempe, Ken Yamaji, Naoto Tamura & Yoshinari Takasaki. (2012) Recent trends in use of nonbiologic DMARDs and evaluation of their continuation rates in single and dual combination therapies in rheumatoid arthritis patients in Japan. Modern Rheumatology 22:6, pages 831-836.
Read now
Read now
N Tugnet, SC Cooper & KM Douglas. (2012) Methotrexate therapy, rheumatoid arthritis, and life-threatening liver complications: should we be monitoring more closely?. Scandinavian Journal of Rheumatology 41:2, pages 163-164.
Read now
Read now
T. Kuitunen, J. Malmström, E. Palva & T. Pettersson. (2005) Pancytopenia induced by low‐dose methotrexate. A study of the cases reported to the Finnish Adverse Drug Reaction Register from 1991 to 1999. Scandinavian Journal of Rheumatology 34:3, pages 238-241.
Read now
Read now
Articles from other publishers (24)
Mepur H. Ravindranath, Narendranath M. Ravindranath, Carly J. Amato-Menker, Fatiha El Hilali, Senthamil R. Selvan, Edward J. Filippone & Luis Eduardo Morales-Buenrostro. (2023) Antibodies for β2-Microglobulin and the Heavy Chains of HLA-E, HLA-F, and HLA-G Reflect the HLA-Variants on Activated Immune Cells and Phases of Disease Progression in Rheumatoid Arthritis Patients under Treatment. Antibodies 12:2, pages 26.
Crossref
Crossref
Krista L. Haines, Laura Gorenshtein, Stephanie Lumpkin, Braylee Grisel & Scott Gallagher. (2023) Optimal Nutrition in the Older Adult: Beneficial Versus Ineffective Supplements. Current Nutrition Reports 12:2, pages 231-237.
Crossref
Crossref
Diane Bramley. (2021) What dose of folic acid to use with methotrexate in rheumatoid arthritis?. Drug and Therapeutics Bulletin 59:7, pages 103-106.
Crossref
Crossref
Jacqueline Rodríguez, Gloria Inés Lafaurie, Wilson Bautista-Molano, Lorena Chila-Moreno, Juan Manuel Bello-Gualtero & Consuelo Romero-Sánchez. (2020) Adipokines and periodontal markers as risk indicators of early rheumatoid arthritis: a cross-sectional study. Clinical Oral Investigations 25:4, pages 1685-1695.
Crossref
Crossref
S. Kreft. 2015. Dietary Supplements. Dietary Supplements
127
135
.
S.R. Zwart, C.R. Gibson & S.M. Smith. 2014. Handbook of Nutrition, Diet and the Eye. Handbook of Nutrition, Diet and the Eye
393
399
.
Stephanie Klemencic. (2010) Cotton wool spots as an indicator of methotrexate-induced blood dyscrasia. Optometry - Journal of the American Optometric Association 81:4, pages 177-180.
Crossref
Crossref
Christian Pagnoux & Michelle Goulet. (2009) Role and place of methotrexate in vasculitis management. International Journal of Clinical Rheumatology 4:6, pages 697-715.
Crossref
Crossref
N. Varatharajan, I. G. S. Lim, A. Anandacoomarasamy, R. Russo, K. Byth, D. G. Spencer, N. Manolios & G. B. Howe. (2009) Methotrexate: long-term safety and efficacy in an Australian consultant rheumatology practice. Internal Medicine Journal 39:4, pages 228-236.
Crossref
Crossref
Patricia Worthington & Leslie Schechter. 2010. Handbook of Drug-Nutrient Interactions. Handbook of Drug-Nutrient Interactions
513
536
.
Mary Kay Koenig, Maria Perez, Sheldon Rothenberg & Ian J. Butler. (2007) Juvenile Onset Central Nervous System Folate Deficiency and Rheumatoid Arthritis. Journal of Child Neurology 23:1, pages 106-107.
Crossref
Crossref
P. Goldsmith & A. Roach. (2007) Methods to enhance the safety of methotrexate prescribing. Journal of Clinical Pharmacy and Therapeutics 32:4, pages 327-331.
Crossref
Crossref
E. Mitre, K. R. Talaat, M. R. Sperling & T. E. Nash. (2007) Methotrexate as a Corticosteroid-Sparing Agent in Complicated Neurocysticercosis. Clinical Infectious Diseases 44:4, pages 549-553.
Crossref
Crossref
K Robien, M M Schubert, Y Yasui, P Martin, R Storb, J D Potter & C M Ulrich. (2006) Folic acid supplementation during methotrexate immunosuppression is not associated with early toxicity, risk of acute graft-versus-host disease or relapse following hematopoietic transplantation. Bone Marrow Transplantation 37:7, pages 687-692.
Crossref
Crossref
Bruce E. Strober & Kavita Menon. (2005) Folate supplementation during methotrexate therapy for patients with psoriasis. Journal of the American Academy of Dermatology 53:4, pages 652-659.
Crossref
Crossref
Kim Robien. (2017) Folate During Antifolate Chemotherapy: What We Know... and Do Not Know. Nutrition in Clinical Practice 20:4, pages 411-422.
Crossref
Crossref
Bruce N. Cronstein. (2005) Low-Dose Methotrexate: A Mainstay in the Treatment of Rheumatoid Arthritis. Pharmacological Reviews 57:2, pages 163-172.
Crossref
Crossref
Gerry Clare, Stephen Colley, Robin Kennett & John S Elston. (2005) Reversible Optic Neuropathy Associated With Low-Dose Methotrexate Therapy. Journal of Neuro-Ophthalmology 25:2, pages 109-112.
Crossref
Crossref
G M J Deeming, J Collingwood & M N Pemberton. (2005) Methotrexate and oral ulceration. British Dental Journal 198:2, pages 83-85.
Crossref
Crossref
James T. Cassidy & Ross E. Petty. 2005. Textbook of Pediatric Rheumatology. Textbook of Pediatric Rheumatology
206
260
.
Sarah L. Morgan, Robert A. Oster, Jeannette Y. Lee, Graciela S. Alarcón & Joseph E. Baggott. (2004) The effect of folic acid and folinic acid supplements on purine metabolism in methotrexate‐treated rheumatoid arthritis. Arthritis & Rheumatism 50:10, pages 3104-3111.
Crossref
Crossref
Shumin M. Zhang & Walter C. Willett. 2004. Cancer Chemoprevention. Cancer Chemoprevention
559
582
.
Urspeter Masche. (2002) Basistherapie der rheumatoiden Arthritis. pharma-kritik 24:3.
Crossref
Crossref
Eva Reinhold‐Keller, Claudia O. E. Fink, Karen Herlyn, Wolfgang L. Gross & Kirsten de Groot. (2002) High rate of renal relapse in 71 patients with Wegener's granulomatosis under maintenance of remission with low‐dose methotrexate. Arthritis Care & Research 47:3, pages 326-332.
Crossref
Crossref